Patients with glomerular disease may first present to primary care, internal medicine, general nephrology, or a subspecialist, yet differences in expertise and access can contribute to delayed diagnosis and treatment. To reduce this variability, the American Society of Nephrology developed the Glomerular Diseases Collaborative Compendium, a curated resource covering ANCA-associated vasculitis, IgA nephropathy, lupus nephritis, C3 glomerulopathy, and membranous nephropathy. A recognition-to-referral pathway is designed to help nonspecialists identify possible active glomerular disease, determine which initial tests to obtain, assess disease activity, and recognize when specialist referral is warranted. The resource is intended to complement, not replace, clinical guidelines while providing more rapidly updated information in an increasingly complex treatment landscape.

For day-to-day practice, the compendium also brings together landmark studies and clinical trials, disease biology, mechanisms of action, newer therapies, monitoring considerations, and practical prescribing guidance. Resources addressing treatment access provide support for prior authorization, documentation, referrals, and appeals—administrative barriers that can influence whether patients receive newer therapies. The platform is designed to meet clinicians at different levels of expertise, from those asking whether a patient may have glomerular disease to specialists comparing advanced treatment and monitoring strategies. An evolving effort to incorporate patient perspectives further supports the broader goal: more consistent, timely glomerular disease management regardless of where patients enter the healthcare system.

Reference: Vasquez-Rios G. How the ASN’s GD-C Compendium aims to unify glomerular disease care. HCP Live. Published September 22, 2026. Accessed October 6, 2026. https://www.hcplive.com/view/how-the-asn-s-gd-c-compendium-aims-to-unify-glomerular-disease-care

Link: https://www.hcplive.com/view/how-the-asn-s-gd-c-compendium-aims-to-unify-glomerular-disease-care